| 1 |
Correlating precipitation inhibition efficacy of EUD EPO and PVP K30 on supersaturated solution of atorvastatin calcium with Caco-2 permeability enhancement |
|
|
| Santhosh Sunnam,Ikjot Sodhi,Prachi Joshi,Sanjaya K. Samal,Abhay T. Sangamwar |
|
| Journal of Drug Delivery Science and Technology. 2020; 57: 101692 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Development and in vitro evaluation of gel formulation of atorvastatin solid dispersions |
|
|
| A.Isilay Özdogan,Gülçin Akca,Sevda Senel |
|
| Journal of Drug Delivery Science and Technology. 2020; : 102199 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Does the trihydrate of atorvastatin calcium possess a melting point? |
|
|
| Chaima Tizaoui,Haykel Galai,Maria Barrio,Simon Clevers,Nicolas Couvrat,Valérie Dupray,Gérard Coquerel,Josep-Lluis Tamarit,Ivo B. Rietveld |
|
| European Journal of Pharmaceutical Sciences. 2020; : 105334 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions |
|
|
| Xiangjun Shi,Tiantian Xu,Wan Huang,Baibai Fan,Xiaoxia Sheng |
|
| AAPS PharmSciTech. 2019; 20(4) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Highly Water-Soluble Solid Dispersions of Honokiol: Preparation, Solubility, and Bioavailability Studies and Anti-Tumor Activity Evaluation |
|
|
| Xiaoxia Wang,Xiaoxia Wu,Xiaoxia Wang,Xiaoxia Wang,Xiaoxia Zhao |
|
| Pharmaceutics. 2019; 11(11): 573 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
In Vitro-In Vivo Evaluation of Novel Co-spray Dried Rifampicin Phospholipid Lipospheres for Oral Delivery |
|
|
| Charan Singh,L. V. Seshu Kumar Koduri,Tara Datt Bhatt,Sarbjit Singh Jhamb,Vijay Mishra,Manjinder Singh Gill,Sarasija Suresh |
|
| AAPS PharmSciTech. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Atorvastatin–cyclodextrin systems: Physiochemical and biopharmaceutical evaluation |
|
|
| Mohanraj Palanisamy,Apollo James,Jasmina Khanam |
|
| Journal of Drug Delivery Science and Technology. 2016; 31: 41 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Formulation development and systematic optimization of stabilized ziprasidone hydrochloride capsules devoid of any food effect |
|
|
| Sabyasachi Banerjee,K. Ravi Shankar,Rajendra Prasad Y. |
|
| Pharmaceutical Development and Technology. 2015; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
